According to a report, 2020 was a record year for private equity investment in the healthcare and life sciences segment. Pharmaceuticals accounted for a majority of the $2.5 billion invested in this sector. There are several factors behind this outstanding influx of investments in Indian healthcare. For one, the size of the opportunity is enormous: India’s healthcare industry is expected to reach over $372 billion by 2022. Much of India’s primary healthcare remains unorganized, which presents opportunities across the board.